ESH Video

#ESHCML2023 STARTS IN 10 DAYS, LAST CHANCE TO REGISTER!

September 27, 2023

25th ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY

 

October 6-8, 2023
Mandelieu-La Napoule, France - #ESHCML2023

 

 

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa

Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Danilo Perrotti, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

 


 

 

THE CONFERENCE STARTS ON
Friday, October 6th

DO NOT MISS THE OPPORTUNITY, join us in the South of France:

 

 
 
 

 

PROGRAM HIGHLIGHT:
4 KEYNOTE LECTURES

 

 


ABOUT THE CONFERENCE

 

The program includes the latest in research in chronic myeloid leukemia, including basic, translational and clinical research with an emphasis on open discussion among participants. There are also scientific workshops to discuss the latest technologies of value in CML research, and clinical symposia with focus on topics of interest to the CML community. There are special lectures on topics of general interest to the CML community from lead experts in their field. The program is designed to encourage discussion and collaboration among participants, presenters and attendees.

 


 

2023 John Goldman charity Fun Run, organized by the iCMLf during the ESH-iCMLf 25th Annual John Goldman Conference on CML in Mandelieu-La Napoule, France.

All funds raised through this charity run will support the work of the iCMLf to improve outcomes for people with CML around the world.


Donate to the iCMLf and receive a Fun run charity t-shirt.
 
CLICK HERE TO REGISTER FOR THE FUN RUN!

*
PROGRAMFACULTY - MORE INFORMATION

 


 

With the support of*:
 



Diamond Conference Partner
*******

NOVARTIS

Emerald Conference Partner
*******


Ruby Conference Partner
******


*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.